Similar Papers

Paper Title
Journal
Date
Author
Abstract OT3-02-02: ENDEAR: A randomized international phase 3 study comparing the efficacy and safety of enzalutamide in combination with paclitaxel chemotherapy or as monotherapy vs placebo with paclitaxel in patients with advanced diagnostic-positive triple-negative breast cancer
R Dent ... S-B Kim
Cancer Research | VOL. 77
R Dent, et. al.R Dent ... S-B Kim
14 Feb 2017
Androgen receptor-positive, triple-negative breast cancer.
Ayca Gucalp ... Tiffany A Traina
Cancer | VOL. 123
Ayca Gucalp, et. al.Ayca Gucalp ... Tiffany A Traina
12 Apr 2017
Abstract 378: Predictive and pharmacodynamic biomarkers of the androgen receptor in circulating tumor cells
Jamie M Sperger ... Erika Heninger
Cancer Research | VOL. 75
Jamie M Sperger, et. al.Jamie M Sperger ... Erika Heninger
01 Aug 2015
Enzalutamide, an androgen receptor signaling inhibitor, induces tumor regression in a mouse model of castration‐resistant prostate cancer
Javier Guerrero ... Andrew A Protter
The Prostate | VOL. 73
Javier Guerrero, et. al.Javier Guerrero ... Andrew A Protter
13 Jun 2013
View more papers

More From: European Journal of Cancer

Paper Title
Journal
Date
Author
Cancer-Specific Utility Instrument for Health Economic Evaluations: A Synopsis of the EORTC QLU-C10D User Manual and Current Validity Evidence
Simone Seyringer ... Eva M Gamper
European Journal of Cancer | VOL. -
Simone Seyringer, et. al.Simone Seyringer ... Eva M Gamper
01 Jan 2025
Editorial Board
-
European Journal of Cancer | VOL. 215
--
01 Jan 2025
Incidence and survival of European adolescents and young adults diagnosed with sarcomas: EUROCARE-6 results
Annalisa Trama ... Salvatore Provenzano
European Journal of Cancer | VOL. -
Annalisa Trama, et. al.Annalisa Trama ... Salvatore Provenzano
01 Jan 2025
Characteristics and outcomes in patients with lenalidomide-refractory multiple myeloma treated with 1-3 prior lines of therapy: analysis of individual patient-level data from daratumumab clinical trials
Kwee Yong ... Binod Dhakal
European Journal of Cancer | VOL. 215
Kwee Yong, et. al.Kwee Yong ... Binod Dhakal
01 Jan 2025
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.